| 1073 |
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
|
2026-09-28 |
231 |
| 1072 |
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
|
2026-09-28 |
200 |
| 1071 |
Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.
|
2026-09-28 |
194 |
| 1070 |
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
|
2026-08-31 |
306 |
| 1069 |
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
|
2026-08-31 |
417 |
| 1068 |
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
|
2026-08-31 |
336 |
| 1067 |
ATLAS, Lancet 2026
|
2026-07-30 |
425 |
| 1066 |
TRACE-5 BAO, Lancet 2026
|
2026-07-30 |
453 |
| 1065 |
ORIENTAL MEVO Trial, NEJM 2026
|
2026-07-30 |
409 |
| 1064 |
CHAMPION-AF와 CLOSURE-A:우리는 누구에게 LAAC를 해야 하는가?
|
2026-06-30 |
538 |
| 1063 |
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
|
2026-06-30 |
512 |
| 1062 |
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
|
2026-06-30 |
454 |
| 1061 |
Increased Risk of Ischemic Events in Patients With Stroke Treated With Clopidogrel and a P-CAB or PPI
|
2026-05-28 |
1,432 |
| 1060 |
Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke—ACTISAVE
|
2026-05-28 |
628 |
| 1059 |
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation The STABLED Randomized Clinical Trial
|
2026-05-28 |
605 |
HOME
LOGIN
